BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20350806)

  • 1. Inhibition of gamma-secretase by the CK1 inhibitor IC261 does not depend on CK1delta.
    Höttecke N; Liebeck M; Baumann K; Schubenel R; Winkler E; Steiner H; Schmidt B
    Bioorg Med Chem Lett; 2010 May; 20(9):2958-63. PubMed ID: 20350806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner.
    Yuan F; Li D; Guo M; Fang T; Sun J; Qi F; Rao Q; Zhao Z; Huang P; Yang B; Xia J
    Biochem Biophys Res Commun; 2020 Mar; 523(3):809-815. PubMed ID: 31954519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo.
    Brockschmidt C; Hirner H; Huber N; Eismann T; Hillenbrand A; Giamas G; Radunsky B; Ammerpohl O; Bohm B; Henne-Bruns D; Kalthoff H; Leithäuser F; Trauzold A; Knippschild U
    Gut; 2008 Jun; 57(6):799-806. PubMed ID: 18203806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.
    Cheong JK; Nguyen TH; Wang H; Tan P; Voorhoeve PM; Lee SH; Virshup DM
    Oncogene; 2011 Jun; 30(22):2558-69. PubMed ID: 21258417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubules depolymerization caused by the CK1 inhibitor IC261 may be not mediated by CK1 blockage.
    Stöter M; Krüger M; Banting G; Henne-Bruns D; Knippschild U
    PLoS One; 2014; 9(6):e100090. PubMed ID: 24937750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer.
    Liu M; Hu Y; Lu S; Lu M; Li J; Chang H; Jia H; Zhou M; Ren F; Zhong J
    Int J Biol Sci; 2020; 16(5):882-892. PubMed ID: 32071557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural optimization of a CXCR2-directed antagonist that indirectly inhibits gamma-secretase and reduces Abeta.
    Bakshi P; Jin C; Broutin P; Berhane B; Reed J; Mullan M
    Bioorg Med Chem; 2009 Dec; 17(23):8102-12. PubMed ID: 19853461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rationale for Drug Design Provided by Co-Crystal Structure of IC261 in Complex with Tubulin.
    Xian J; Bu F; Wang Y; Long F; Zhang Z; Wu C; Tao Y; Wang T; Wang G
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33579052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituted 2-oxo-azepane derivatives are potent, orally active gamma-secretase inhibitors.
    Kitas EA; Galley G; Jakob-Roetne R; Flohr A; Wostl W; Mauser H; Alker AM; Czech C; Ozmen L; David-Pierson P; Reinhardt D; Jacobsen H
    Bioorg Med Chem Lett; 2008 Jan; 18(1):304-8. PubMed ID: 17983746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,6-Disubstituted N-arylsulfonyl piperidines as gamma-secretase inhibitors.
    Pissarnitski DA; Asberom T; Bara TA; Buevich AV; Clader JW; Greenlee WJ; Guzik HS; Josien HB; Li W; McEwan M; McKittrick BA; Nechuta TL; Parker EM; Sinning L; Smith EM; Song L; Vaccaro HA; Voigt JH; Zhang L; Zhang Q; Zhao Z
    Bioorg Med Chem Lett; 2007 Jan; 17(1):57-62. PubMed ID: 17055268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State-dependent block of voltage-gated sodium channels by the casein-kinase 1 inhibitor IC261.
    Föhr KJ; Knippschild U; Herkommer A; Fauler M; Peifer C; Georgieff M; Adolph O
    Invest New Drugs; 2017 Jun; 35(3):277-289. PubMed ID: 28164251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydroquinoline sulfonamides as gamma-secretase inhibitors.
    Asberom T; Bara TA; Clader JW; Greenlee WJ; Guzik HS; Josien HB; Li W; Parker EM; Pissarnitski DA; Song L; Zhang L; Zhao Z
    Bioorg Med Chem Lett; 2007 Jan; 17(1):205-7. PubMed ID: 17046254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting.
    Rajendran L; Schneider A; Schlechtingen G; Weidlich S; Ries J; Braxmeier T; Schwille P; Schulz JB; Schroeder C; Simons M; Jennings G; Knölker HJ; Simons K
    Science; 2008 Apr; 320(5875):520-3. PubMed ID: 18436784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretase inhibitors and modulators for Alzheimer's disease treatment.
    Tomita T
    Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulators and inhibitors of gamma- and beta-secretases.
    Schmidt B; Baumann S; Narlawar R; Braun HA; Larbig G
    Neurodegener Dis; 2006; 3(4-5):290-7. PubMed ID: 17047370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.
    Pu J; Kreft AF; Aschmies SH; Atchison KP; Berkowitz J; Caggiano TJ; Chlenov M; Diamantidis G; Harrison BL; Hu Y; Huryn D; Steven Jacobsen J; Jin M; Lipinski K; Lu P; Martone RL; Morris K; Sonnenberg-Reines J; Riddell DR; Sabalski J; Sun SC; Wagner E; Wang Y; Xu Z; Zhou H; Resnick L
    Bioorg Med Chem; 2009 Jul; 17(13):4708-17. PubMed ID: 19443228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of casein kinase I delta alters mitotic spindle formation and induces apoptosis in trophoblast cells.
    Stöter M; Bamberger AM; Aslan B; Kurth M; Speidel D; Löning T; Frank HG; Kaufmann P; Löhler J; Henne-Bruns D; Deppert W; Knippschild U
    Oncogene; 2005 Dec; 24(54):7964-75. PubMed ID: 16027726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression levels of Casein kinase 1 (CK1) isoforms are correlated to adiponectin levels in adipose tissue of morbid obese patients and site-specific phosphorylation mediated by CK1 influences multimerization of adiponectin.
    Xu P; Fischer-Posovszky P; Bischof J; Radermacher P; Wabitsch M; Henne-Bruns D; Wolf AM; Hillenbrand A; Knippschild U
    Mol Cell Endocrinol; 2015 May; 406():87-101. PubMed ID: 25724478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of a promiscuous inhibitor shifts the inhibition from γ-secretase to FLT-3.
    Amombo GM; Kramer T; Lo Monte F; Göring S; Fach M; Smith S; Kolb S; Schubenel R; Baumann K; Schmidt B
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7634-40. PubMed ID: 23107479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.